RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples